6月5日,石药集团(01093)发布公告,本公司开发的腺苷钴胺胶囊(0.5mg)已获得中华人民共和国国家药品监督管理局颁发的药品注册批件,视同通过仿制药质量和疗效一致性评价。
该产品属于维生素B12类药物,适用于治疗巨幼红细胞性贫血、营养不良性贫血、妊娠期贫血等多种疾病。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.